Horm Metab Res 2007; 39(8): 575-581
DOI: 10.1055/s-2007-985132
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Discoidin Domain Receptor 2 Impairs Insulin-stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Glucose Uptake in 3T3-L1 Adipocytes

H. Zurakowski 1 , A. Gagnon 1 , A. Landry 1 , M. D. Layne 2 , A. Sorisky 1
  • 1Departments of Medicine and of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa Health Research Institute, Ottawa, ON K1Y 4E9 Canada
  • 2Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, Boston, USA
Weitere Informationen

Publikationsverlauf

received 27.11.2006

accepted 27.02.2007

Publikationsdatum:
21. August 2007 (online)

Preview

Abstract

Differentiation of preadipocytes into functional adipocytes depends on early proliferative events (mitotic clonal expansion) and extracellular matrix interactions. We report that discoidin domain receptor (DDR) 2, a novel adhesion receptor, is expressed in 3T3-L1 preadipocytes and is downregulated during the early phase of adipogenesis. DDR2 overexpression (DDR2-L1 preadipocytes) reduced subconfluent proliferation by 56% (p<0.001) and insulin-stimulated tyrosine phosphorylation of insulin receptor substrate (IRS)-1 by 34% (p<0.05). The mitotic clonal expansion phase of differentiating confluent DDR2-L1 preadipocytes was impaired by ∼25% (p<0.05). Although induction of peroxisome proliferator-activated receptor γ, fatty acid synthase, and adiponectin was not altered, the resulting adipocytes were 55% larger (p<0.05), and contained 66% more triacylglycerol (p<0.01). The induction of CCAAT/enhancer binding protein α was reduced by 37% (p<0.05), correlating with a similar reduction in insulin-stimulated IRS-1 tyrosine phosphorylation and glucose transport in DDR2-L1 adipocytes (decreases of 22% and 27%, respectively; p<0.05 for both). Our data show that DDR2 is expressed in adipose cells and that its overexpression leads to insulin resistance.

References

Correspondence

Dr. A. Sorisky

Ottawa Health Research Institute

725 Parkdale Avenue

Ottawa ON K1Y 4E9

Canada

Telefon: +1/613/798 55 55 175 72

Fax: +1/613/761 50 36

eMail: asorisky@ohri.ca